| 5.35 0 (0%) | 06-12 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 6.76 | 1-year : | 7.89 |
| Resists | First : | 5.78 | Second : | 6.76 |
| Pivot price | 5.3 |
|||
| Supports | First : | 4.28 | Second : | 3.34 |
| MAs | MA(5) : | 5.19 |
MA(20) : | 5.22 |
| MA(100) : | 3.14 |
MA(250) : | 4.7 |
|
| MACD | MACD : | 0.3  |
Signal : | 0.4 |
| %K %D | K(14,3) : | 44.9 |
D(3) : | 43.3 |
| RSI | RSI(14): 60.2 | |||
| 52-week | High : | 12 | Low : | 1.5 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ AIRS ] has closed below upper band by 44.5%. Bollinger Bands are 42.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 5.66 - 5.69 | 5.69 - 5.71 |
| Low: | 5.23 - 5.26 | 5.26 - 5.29 |
| Close: | 5.3 - 5.35 | 5.35 - 5.4 |
AirSculpt Technologies, Inc. operates as a holding company, overseeing its subsidiaries, including EBS Intermediate Parent LLC, which specializes in providing body contouring services throughout the United States. The company's flagship offering is its unique AirSculpt procedure, a minimally invasive method for custom body sculpting through the precise removal of unwanted fat. Beyond targeted fat reduction, AirSculpt also performs fat transfer procedures, utilizing a patient's own adipose cells to naturally augment areas such as the breasts, buttocks, or hips. Notable specialized treatments include the Power BBL, a Brazilian butt lift; the Up a Cup for breast enhancement; and the Hip Flip, designed to achieve an hourglass silhouette. As of March 10, 2022, AirSculpt maintained a network of 19 operational centers across 15 U.S. states. Established in 2012, AirSculpt Technologies, Inc. has its corporate headquarters situated in Miami Beach, Florida.
Tue, 09 Jun 2026
AIRS: Positive sales momentum and new GLP-1 services drive growth, with expansion plans ahead - TradingView
Mon, 01 Jun 2026
Aaron Rollins discloses 20.9% stake in AirSculpt Technologies (AIRS) via Schedule 13G - Stock Titan
Wed, 27 May 2026
AirSculpt Technologies Announces Participation in Upcoming Investor Conferences - Moomoo
Wed, 27 May 2026
Cosmetic firm AirSculpt lines up TD Cowen and Oppenheimer investor talks - Stock Titan
Wed, 20 May 2026
Fund linked to Airsculpt (AIRS) shifts 5.17M shares in-kind - Stock Titan
Tue, 31 Mar 2026
AirSculpt Technologies Inc. (AIRS) Stock Falls on Q4 2025 Earnings | AIRS Stock News - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 71 (M) |
| Shares Float | 15 (M) |
| Held by Insiders | 43 (%) |
| Held by Institutions | 66 (%) |
| Shares Short | 4,170 (K) |
| Shares Short P.Month | 4,900 (K) |
| EPS | -0.18 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.41 |
| Profit Margin | -7.4 % |
| Operating Margin | -4.6 % |
| Return on Assets (ttm) | -1.7 % |
| Return on Equity (ttm) | -12.7 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 1.42 |
| Sales Per Share | 2.15 |
| EBITDA (p.s.) | 0.1 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 8 (M) |
| Levered Free Cash Flow | 13 (M) |
| PE Ratio | -31.48 |
| PEG Ratio | 0 |
| Price to Book value | 3.76 |
| Price to Sales | 2.48 |
| Price to Cash Flow | 50.32 |
| Dividend | 0.4 |
| Forward Dividend | 0 |
| Dividend Yield | 7.6% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|